ArticleVaccines2024

Validation and Suitability Assessment of Multiplex Mesoscale Discovery Immunogenicity Assay for Establishing Serological Signatures Using Vaccinated, Non-Vaccinated and Breakthrough SARS-CoV-2 Infected Cases.

Sushant Shengule et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.